What Have We Learned From COVID-19 in Business and Management and What Are the Future Challenges?

被引:1
|
作者
Escamilla-Solano, Sandra [1 ]
Diez-Martin, Francisco [1 ]
Blanco-Gonzalez, Alicia [1 ]
de las Penas, Cesar Fernandez [1 ]
机构
[1] Univ Rey Juan Carlos, Paseo Artilleros s-n, Madrid 28032, Spain
关键词
COVID-19; bibliometrics; CiteSpace; co-citation; challenges; business; management; GRAND CHALLENGES; TRENDS;
D O I
10.1177/00027642231191752
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The COVID-19 pandemic has created a number of business challenges that have highlighted latent business problems. In the search for solutions, academics have produced over 3,000 research articles in the field of business and management research. This research focuses on what we have learned from COVID-19 in business and management and on the future challenges for researchers. To outline the research that has been generated on the impact of COVID-19 on companies, we developed a bibliometric analysis to describe the intellectual structure of the field, identifying the main challenges for companies (Supply Chain, Consumer Behavior, SMEs, Stock Market, Tourism, ICTs, Work Stress, Cyberchondria, Education, Social Challenge, Teleworking); the ways in which scholars are developing solutions to these challenges; the main sources of knowledge in the area; and the future research challenges.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Obesity and Infection: What Have We Learned From the COVID-19 Pandemic
    Vassilopoulou, Emilia
    Bumbacea, Roxana Silvia
    Pappa, Aikaterini Konstantina
    Papadopoulos, Athanasios N.
    Bumbacea, Dragos
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [32] WHAT HAVE WE LEARNED FROM THE D-DIMER IN COVID-19?
    Garcia, Leon N.
    Calderon, Lopez M. T.
    Hidalgo, Gomez-Arevalillo
    Martin-Serrano, Martin P.
    Alonso, Gomez N.
    Jareno, Esteban J.
    Matilla, Garcia A.
    [J]. HAEMATOLOGICA, 2021, 106 (10) : 327 - 328
  • [33] The COVID-19 Pandemic: What We Have Learned from Thai Experiences
    Malathum, Kumthorn
    Malathum, Porntip
    [J]. PACIFIC RIM INTERNATIONAL JOURNAL OF NURSING RESEARCH, 2020, 24 (04): : 431 - 435
  • [34] Management of acute kidney injury associated with Covid-19: what have we learned?
    Cottam, Daniel
    Nadim, Mitra K.
    Forni, Lui G.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (06): : 563 - 570
  • [35] From SARS to COVID-19: What we have learned about children infected with COVID-19
    Zhou, Meng-Yao
    Xie, Xiao-Li
    Peng, Yong-Gang
    Wu, Meng-Jun
    Deng, Xiao-Zhi
    Wu, Ying
    Xiong, Li-Jing
    Shang, Li-Hong
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 96 : 710 - 714
  • [36] KEY CHALLENGES IN MODELLING AN EPIDEMIC - WHAT HAVE WE HAVE LEARNED FROM THE COVID-19 EPIDEMIC SO FAR
    Erzen, Ivan
    Kamensek, Tina
    Fosnaric, Miha
    Zibert, Janez
    [J]. ZDRAVSTVENO VARSTVO, 2020, 59 (03): : 117 - 119
  • [37] Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?
    Giannis, Dimitrios
    Douketis, James D.
    Spyropoulos, Alex C.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 13 - 16
  • [38] Micronutrients in Sepsis and COVID-19: A Narrative Review on What We Have Learned and What We Want to Know in Future Trials
    Rossetti, Matteo
    Martucci, Gennaro
    Starchl, Christina
    Amrein, Karin
    [J]. MEDICINA-LITHUANIA, 2021, 57 (05):
  • [39] The role of vaccines in the COVID-19 pandemic: what have we learned?
    Krammer, Florian
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2024, 45 (4-6) : 451 - 468
  • [40] What have we learned in the 3 years of the COVID-19 pandemic?
    Maisch, Bernhard
    Doerr, Rolf
    [J]. HERZ, 2023, 48 (03) : 169 - 172